The histological diagnosis of endometrial hyperplasia is there a need to simplify?

Virchows Archiv

Volumn 439, Issue 5, 2001, Pages 604-608

  Dietel, M ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Classification Endometrial intraepithelial neoplasia; Clinical treatment; Endometrial carcinoma; Endometrial hyperplasia

Indexed keywords

GESTAGEN; HORMONE;

CANCER CLASSIFICATION; CANCER GRADING; CANCER RISK; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM HYPERPLASIA; HISTOLOGY; HORMONAL THERAPY; HUMAN; MORPHOMETRICS; NEOPLASM; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; REVIEW; STROMA; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

EID: 0035170848     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280100503     Document Type: Review

References (36)

1. Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features alone
2. Assessment of the risk on endometrial cancer in hyperplasia, by means of morphological and morphometrical features
3. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens
4. Reply to letter to the editor by Scully RE and Young RH
5. Expression of nm23 in normal, hyperplastic and neoplastic endometrial tissues
6. Endometrial hyperplasia and endometrial cancer
7. Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer
8. Hyperplasia vs neoplasia: Two tracks for endometrium?
9. The endometrial hyperplasia and their relationship to endometrial neoplasia
10. The endometrial hyperplasia
11. Pathological findings and prognosis from uterine malignancies
12. Endometrial hyperplasia
13. Interinstitutional surgical pathology review in gynecologic oncology: I. Cancer in endometrial curettings and biopsies
14. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma
15. Genetic imbalances in precursor lesions of endometrial cancer detected by comparative genomic hybridization
16. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma
17. The behavior of endometrial hyperplasia: A long term study of "untreated" hyperplasia in 170 patients
18. A dualistic model for endometrial carcinogenesis based on immunhistochemical and molecular genetic analyses
19. DNA ploidy, cell cycle kinetics, and low versus high grade atypia in endometrial hyperplasia
20. K-ras mutations appear in the premalignant phase of both micro-satellite stable and unstable endometrial carcinogenesis
21. Endometrial intraepithelial neoplasia (EIN): Will it bring order to chaos?
22. Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry
23. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium
24. A comparative morphometric and cytophotometric study of endometrial hyperplasia, atypical hyperplasia and carcinoma
25. WAF1/CIP1 in normal, hyperplastic and neoplastic uterine tissue
26. The precursors of endometrial carcinoma
27. Telomerase expression in normal endometrium, endometrial hyperplasia and endometrial adenocarcinomas
28. Problems in the differential diagnosis of endometrial hyperplasia and carcinoma
29. Lectin-binding patter in normal, hyperplastic and neoplastic endometrium: The prognostic value of concanavalin
30. Endometrial lesions in uteri resected for atypical endometrial hyperplasia
31. The behavior of endometrial hyperplasia: A prospective study Endometrial Hyperplasia Study Group
32. Review Endometrial hyperplasia - Diagnosis and treatment
33. Prognostic value of quantitative pathologic features and DNA content in individual patients with stage I endometrial adenocarcinomas